These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 11156247

  • 1. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 2. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
    Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP.
    Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
    [Abstract] [Full Text] [Related]

  • 3. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
    Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.
    Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546
    [Abstract] [Full Text] [Related]

  • 5. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 7. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 8. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP.
    Cancer Res; 2000 Apr 15; 60(8):2290-9. PubMed ID: 10786697
    [Abstract] [Full Text] [Related]

  • 12. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
    Clin Cancer Res; 2002 Jul 15; 8(7):2389-98. PubMed ID: 12114444
    [Abstract] [Full Text] [Related]

  • 13. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.
    Clin Cancer Res; 1998 Dec 15; 4(12):2957-66. PubMed ID: 9865906
    [Abstract] [Full Text] [Related]

  • 14. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
    Inoue K, Perrotte P, Wood CG, Slaton JW, Sweeney P, Dinney CP.
    Clin Cancer Res; 2000 Nov 15; 6(11):4422-31. PubMed ID: 11106263
    [Abstract] [Full Text] [Related]

  • 15. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
    Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
    Clin Cancer Res; 2003 Feb 15; 9(2):886-99. PubMed ID: 12576464
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R.
    Clin Cancer Res; 2000 May 15; 6(5):1936-48. PubMed ID: 10815919
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR, Tortora G.
    Clin Cancer Res; 1999 Apr 15; 5(4):909-16. PubMed ID: 10213228
    [Abstract] [Full Text] [Related]

  • 18. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
    Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M.
    Clin Cancer Res; 2003 Aug 01; 9(8):3167-75. PubMed ID: 12912969
    [Abstract] [Full Text] [Related]

  • 19. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
    Yazici S, Kim SJ, Busby JE, He J, Thaker P, Yokoi K, Fan D, Fidler IJ.
    Prostate; 2005 Nov 01; 65(3):203-15. PubMed ID: 15948138
    [Abstract] [Full Text] [Related]

  • 20. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
    Fox WD, Higgins B, Maiese KM, Drobnjak M, Cordon-Cardo C, Scher HI, Agus DB.
    Clin Cancer Res; 2002 Oct 01; 8(10):3226-31. PubMed ID: 12374693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.